Results 191 to 200 of about 37,026 (217)

Efficacy and safety of dextromethorphan-bupropion combination (AXS-05) in the treatment of depression: A systematic review and network meta-analysis.

Indian J Pharmacol
Ashwin JV, Shahi MK, Singh A, Kumar ST.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bupropion Hydrochloride

Drug Intelligence & Clinical Pharmacy, 1984
Bupropion is a trimethylated monocyclic phenylaminoketone that is an effective antidepressant in humans. It neither is sedating, anticholinergic, nor cardiotoxic. Its mechanism of action may be related to dopamine, but remains uncertain at this time.Clinical trials comparing bupropion 300–750 mg/d with placebo show it to be superior to placebo in ...
Dufresne, R., Weber, S., Becker, R. E.
openaire   +3 more sources

Bupropion Hydrochloride

2016
Bupropion hydrochloride is a norepinephrine-dopamine disinhibitor (NDDI) approved for the treatment of depression and smoking cessation. Bupropion is a trimethylated monocyclic phenylaminoketone second-generation antidepressant, which differs structurally from most antidepressants, and resides in a novel mechanistic class that has no direct action on ...
S R, Khan, R T, Berendt, C D, Ellison, A B, Ciavarella, E, Asafu-Adjaye, M A, Khan, P J, Faustino   +6 more
openaire   +2 more sources

Bupropion

Reactions Weekly, 2016
Peter Wu, David Juurlink
  +5 more sources

Bupropion

Reactions Weekly, 2015
  +6 more sources

Bupropion

Reactions Weekly, 2023
  +4 more sources